These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6252153)

  • 41. [Use of oral cephalosporins].
    Kujala P
    Duodecim; 1999; 115(20):2241-7. PubMed ID: 11973928
    [No Abstract]   [Full Text] [Related]  

  • 42. [Action and tolerance of cephalexin in infectious processes of the upper respiratory tract in childhood. Apropos of 100 cases].
    Vazquez JR; Vecchio H; Ordoñez A
    Prensa Med Argent; 1971 Aug; 58(24):1242-6. PubMed ID: 5115409
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical experience with cephalexin].
    Lasala FG; Mazzei CM; Castagneto H; Rechniewski C
    Prensa Med Argent; 1971 Mar; 58(2):65-74. PubMed ID: 5091409
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy of cephalexin in common infections in general practice.
    Practitioner; 1970 Dec; 205(230):815-8. PubMed ID: 4924137
    [No Abstract]   [Full Text] [Related]  

  • 45. [Ceftibuten (Cedax)--a novel third generation oral cephalosporin in the treatment of bacterial infections].
    Budanov SV
    Antibiot Khimioter; 1998; 43(4):33-9. PubMed ID: 9606503
    [No Abstract]   [Full Text] [Related]  

  • 46. [Bacteriological and clinical evaluation of cephalosporin preparations in 10 years of experience].
    Catalano G; Abbate GF; Gattoni A; Coraggio F; Altucci P
    G Ital Chemioter; 1977; 24(1-2):39-48. PubMed ID: 615761
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cefditoren and community-acquired lower respiratory tract infections (corrected)].
    Barberán J; Mensa J
    Rev Esp Quimioter; 2009 Sep; 22(3):144-50. PubMed ID: 19662548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cefotaxime in bronchopulmonary infections (author's transl)].
    Kermarec J; Sauvaget J
    Nouv Presse Med; 1981 Feb; 10(8):650-3. PubMed ID: 6259612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of oral cephalosporins in the treatment of upper and lower respiratory tract infections: an overview.
    Klimek JJ
    J Int Med Res; 1980; 8(Suppl 1):77-81. PubMed ID: 7439510
    [No Abstract]   [Full Text] [Related]  

  • 51. Cefepime versus ceftazidime in the treatment of lower respiratory tract infections.
    Aufiero A; Sturani C; Zanon P; Marruchella A; Michetti G; Nicolin E; Sella D; Goglio A; Silleni M; La Regina A
    J Chemother; 1997 Jun; 9(3):213-8. PubMed ID: 9210005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Third-generation cephalosporins: a critical evaluation.
    Barriere SL; Flaherty JF
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The use of cefotaxime against infections (author's transl)].
    Lepeu G; Bertrand A; Armengaud M; Aubertin J
    Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cefamandole in the treatment of purulent respiratory infections. Studies of 3 and 4 g daily in 121 patients.
    Pines A; Jabbar MA; Khorasani MH; Raafat H; Sharma JC
    Chemotherapy; 1981; 27(1):68-72. PubMed ID: 7215006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical evaluation of ceftazidime in the field of pediatrics].
    Koshinami M; Watanabe A
    Jpn J Antibiot; 1984 Mar; 37(3):344-8. PubMed ID: 6376847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapeutic efficacy of ceftibuten in chronic respiratory tract infections].
    Watanabe A; Oizumi K; Motomiya M; Yoshida T; Ito T; Kanayama H; Saito J; Nakai Y; Sato K
    Jpn J Antibiot; 1990 May; 43(5):768-78. PubMed ID: 2391748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is it reasonable to use cephalosporins in respiratory and upper tract renal infections in hospitalized patients?
    Perkins RL
    Bull N Y Acad Med; 1984 May; 60(4):403-15. PubMed ID: 6372916
    [No Abstract]   [Full Text] [Related]  

  • 58. Cephalexin--a new oral antibiotic.
    Bailey A; Walker A; Hadley A; James DG
    Postgrad Med J; 1970 Mar; 46(533):157-8. PubMed ID: 4914633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Meeting the Challenge of Community-Acquired Respiratory Tract Infections: The Role of Cephalosporins. Symposium proceedings. Athens, Greece, May 25, 1992.
    Respiration; 1993; 60 Suppl 1():1-57. PubMed ID: 8097591
    [No Abstract]   [Full Text] [Related]  

  • 60. A double blind clinical trial of cefotaxime and cefazolin in complicated urinary tract infections.
    Ohkawa M; Kuroda K
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():231-3. PubMed ID: 6252162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.